Skip to main content

Table 4 Changes from baseline to 6-month visit in control group

From: Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study

 

Baseline

6-month

Δ from baseline

p

Indexed LVM (g/m2)

90.8 ± 21.0

88.5 ± 22.5

− 2.3 ± 4.1

0.58

LV end-diastolic volume (ml)

97.0 ± 25.7

96.2 ± 26.2

− 0.8 ± 4.7

0.86

LV end-diastolic diameter (mm)

44.5 ± 4.3

45.0 ± 4.2

0.4 ± 0.8

0.57

LV ejection fraction (%)

64.6 ± 5.8

64.4 ± 4.6

− 0.2 ± 1.3

0.89

RWT

0.49 ± 0.08

0.47 ± 0.10

− 0.02 ± 0.02

0.35

GLS

− 19.6 ± 2.5

− 20.0 ± 2.4

− 0.4 ± 0.6

0.34

LA indexed volume (ml/m2)

28.7 ± 9.1

28.9 ± 8.5

0.3 ± 1.4

0.85

E/A ratio

0.81 ± 0.26

0.73 ± 0.20

− 0.08 ± 0.04

0.05

Lateral e’ (cm/s)

8.26 ± 3.24

8.35 ± 2.35

0.09 ± 0.73

0.90

Septal e’ (cm/s)

5.78 ± 1.22

5.95 ± 1.26

0.16 ± 0.23

0.48

E/e’ ratio

9.79 ± 2.44

9.10 ± 2.36

− 0.69 ± 0.68

0.32

  1. LVM left ventricular mass, LV left ventricular, RWT relative wall thickness, GLS global longitudinal strain, LA left atrial